{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:57:01Z","timestamp":1793469421649,"version":"4.5.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Otolaryngol Head Neck Surg"],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:sec id=\"ab-ooi230035-4\"><jats:title>Importance<\/jats:title><jats:p>In the US, oropharyngeal cancer, predominantly caused by high-risk (HR) human papillomavirus (HPV) infection, is the most frequent HPV-associated cancer, surpassing cervical cancer. However, little is known about oral HPV prevalence and genotype distribution in the general population.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi230035-5\"><jats:title>Objective<\/jats:title><jats:p>To assess oral HPV prevalence and factors associated with HR and low-risk infection in a general US population.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi230035-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>PROGRESS (Prevalence of Oral HPV Infection, a Global Assessment) was a cross-sectional observational study conducted between November 2021 and March 2022 in 43 dental offices in the US (24 urban, 13 urban cluster, and 6 rural sites), spanning 21 states. Eligible participants were aged 18 to 60 years, visiting dental clinics for routine dental examination. Dental clinics used targeted sampling to recruit equal distributions of men and women and across age groups.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi230035-7\"><jats:title>Exposure<\/jats:title><jats:p>Participants provided an oral gargle specimen for HPV DNA and genotyping and completed behavioral questionnaires, and dentists reported oral health status. Detection of HPV DNA and genotyping was performed using the SPF10\/DEIA\/LiPA25 system at a central laboratory.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi230035-8\"><jats:title>Main Outcome<\/jats:title><jats:p>Oral HPV prevalence.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi230035-9\"><jats:title>Results<\/jats:title><jats:p>Of the 3196 participants enrolled, mean (SD) age was 39.6 (12.1) years, and 55.5% were women. Oral HPV prevalence was 6.6% (95% CI, 5.7%-7.4%) for any HPV genotype, and 2.0% (95% CI, 1.5%-2.5%), 0.7% (95% CI, 0.4%-1.0%), and 1.5% (95% CI, 1.1%-1.9%) for HR, HPV-16, and 9-valent-HPV vaccine types, respectively. Among HPV-positive participants, HPV-16 was the most prevalent genotype (12.4% among men and 8.6% among women). Prevalence of HPV was higher in men than women and highest among men aged 51 to 60 years (16.8%, 6.8%, and 2.1% for any HPV, HR HPV, and HPV-16, respectively). Factors associated with HR oral infection included being male (adjusted odds ratio [AOR], 3.1; 95% CI, 1.2-8.5), being aged 51 to 60 years (AOR, 3.3; 95% CI, 1.5-7.3), having 26 or more lifetime male sex partners (AOR, 6.5; 95% CI, 2.3-18.7), and having 6 to 25 lifetime female oral sex partners (AOR, 3.4; 95% CI, 1.3-8.7).<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi230035-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this cross-sectional study, oral HPV burden was highest among older men who may be at higher risk of developing oropharyngeal cancer. In addition to male sex and older age, HR oral HPV infection was also associated with sexual behaviors, including increasing number of male sex partners and female oral sex partners.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaoto.2023.1573","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T15:32:25Z","timestamp":1691076745000},"page":"783","source":"Crossref","is-referenced-by-count":49,"title":["Oral Human Papillomavirus Prevalence and Genotyping Among a Healthy Adult Population in the US"],"prefix":"10.1001","volume":"149","author":[{"given":"Anna R.","family":"Giuliano","sequence":"first","affiliation":[{"name":"Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center and Research Institute, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Felsher","sequence":"additional","affiliation":[{"name":"Center for Observational and Real-World Evidence (CORE), Merck & Co, Inc, Rahway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Waterboer","sequence":"additional","affiliation":[{"name":"German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha\u00eftham","family":"Mirghani","sequence":"additional","affiliation":[{"name":"H\u00f4pital Europ\u00e9en Georges-Pompidou, Assistance Publique - H\u00f4pitaux de Paris, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Mehanna","sequence":"additional","affiliation":[{"name":"Institute of Head & Neck Studies and Education (InHANSE), University of Birmingham, Birmingham, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Roberts","sequence":"additional","affiliation":[{"name":"Center for Observational and Real-World Evidence (CORE), Merck & Co, Inc, Rahway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ting","family":"Chen","sequence":"additional","affiliation":[{"name":"Center for Observational and Real-World Evidence (CORE), Merck & Co, Inc, Rahway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lynam","sequence":"additional","affiliation":[{"name":"IQVIA, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montse","family":"Pedr\u00f3s","sequence":"additional","affiliation":[{"name":"IQVIA, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Sanchez","sequence":"additional","affiliation":[{"name":"IQVIA, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Sirak","sequence":"additional","affiliation":[{"name":"Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center and Research Institute, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikha","family":"Surati","sequence":"additional","affiliation":[{"name":"Center for Observational and Real-World Evidence (CORE), Merck & Co, Inc, Rahway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Alemany","sequence":"additional","affiliation":[{"name":"Unit of Molecular Epidemiology and Genetics (UNIC EMG), Cancer Epidemiology Research Program, Catalan Institute of Oncology, ICO, L\u2019Hospitalet, Barcelona, Spain"},{"name":"Bellvitge Biomedical Research Institute (IDIBELL), L\u2019Hospitalet, Barcelona, Spain"},{"name":"CIBER en Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Morais","sequence":"additional","affiliation":[{"name":"MSD France, Puteaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel Angel","family":"Pav\u00f3n","sequence":"additional","affiliation":[{"name":"Bellvitge Biomedical Research Institute (IDIBELL), L\u2019Hospitalet, Barcelona, Spain"},{"name":"CIBER en Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), Madrid, Spain"},{"name":"Laboratory Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, ICO, L\u2019Hospitalet, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"ooi230035r1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.v71.3","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"ooi230035r3","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/jso.v124.6","article-title":"Epidemiology and incidence of HPV-related cancers of the head and neck.","volume":"124","author":"Roman","year":"2021","journal-title":"J Surg Oncol"},{"issue":"2","key":"ooi230035r4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jamaoto.2021.3567","article-title":"Oropharyngeal cancer incidence and mortality trends in all 50 states in the US, 2001-2017.","volume":"148","author":"Damgacioglu","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"33","key":"ooi230035r5","doi-asserted-by":"publisher","first-page":"918","DOI":"10.15585\/mmwr.mm6733a2","article-title":"Trends in human papillomavirus\u2013associated cancers\u2014United States, 1999\u20132015.","volume":"67","author":"Van Dyne","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"ooi230035r6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2014part B: biological agents.","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"ooi230035r7","doi-asserted-by":"publisher","first-page":"F34","DOI":"10.1016\/j.vaccine.2012.05.070","article-title":"Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis.","volume":"30","author":"Gillison","year":"2012","journal-title":"Vaccine"},{"issue":"1-2","key":"ooi230035r8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.virol.2013.06.007","article-title":"Diseases associated with human papillomavirus infection.","volume":"445","author":"Cubie","year":"2013","journal-title":"Virology"},{"issue":"17","key":"ooi230035r9","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/j.vaccine.2021.03.047","article-title":"Oral and laryngeal HPV infection: incidence, prevalence and risk factors, with special regard to concurrent infection in head, neck and genitals.","volume":"39","author":"Wierzbicka","year":"2021","journal-title":"Vaccine"},{"issue":"4","key":"ooi230035r10","doi-asserted-by":"publisher","first-page":"e610","DOI":"10.1093\/pubmed\/fdaa156","article-title":"A systematic review and meta-analysis of the association between periodontitis and oral high-risk human papillomavirus infection.","volume":"43","author":"Ali","year":"2021","journal-title":"J Public Health (Oxf)"},{"key":"ooi230035r11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2021.106630","article-title":"Oral human papillomavirus (HPV) and associated factors among healthy populations: the design of the PROGRESS (PRevalence of Oral hpv infection, a Global aSSessment) study.","volume":"115","author":"Morais","year":"2022","journal-title":"Contemp Clin Trials"},{"issue":"32","key":"ooi230035r12","doi-asserted-by":"publisher","first-page":"698","DOI":"10.15585\/mmwr.mm6832a3","article-title":"Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices.","volume":"68","author":"Meites","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ooi230035r13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jviromet.2015.01.001","article-title":"The original SPF10 LiPA25 algorithm is more sensitive and suitable for epidemiologic HPV research than the SPF10 INNO-LiPA Extra.","volume":"215-216","author":"Geraets","year":"2015","journal-title":"J Virol Methods"},{"issue":"6","key":"ooi230035r14","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0002-9440(10)65688-X","article-title":"Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses.","volume":"153","author":"Kleter","year":"1998","journal-title":"Am J Pathol"},{"issue":"1","key":"ooi230035r15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086023","article-title":"Differences in oral sexual behaviors by gender, age, and race explain observed differences in prevalence of oral human papillomavirus infection.","volume":"9","author":"D\u2019Souza","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"ooi230035r16","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1097\/OLQ.0000000000001405","article-title":"Human papillomavirus vaccine to end oropharyngeal cancer: a systematic review and meta-analysis.","volume":"48","author":"Tsentemeidou","year":"2021","journal-title":"Sex Transm Dis"},{"issue":"7","key":"ooi230035r17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jama.2012.101","article-title":"Prevalence of oral HPV infection in the United States, 2009-2010.","volume":"307","author":"Gillison","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"ooi230035r18","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1186\/s12885-022-10091-8","article-title":"2011-2021 Rising prevalence of HPV infection among oropharyngeal carcinoma in France.","volume":"22","author":"Gorphe","year":"2022","journal-title":"BMC Cancer"},{"issue":"14","key":"ooi230035r19","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1002\/cncr.v124.14","article-title":"Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.","volume":"124","author":"Windon","year":"2018","journal-title":"Cancer"},{"key":"ooi230035r20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.oraloncology.2018.06.013","article-title":"Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of human papillomavirus is attenuated among older patients: analysis of the National Cancer Database.","volume":"83","author":"Rettig","year":"2018","journal-title":"Oral Oncol"},{"issue":"2","key":"ooi230035r21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/ijc.v153.2","article-title":"Oral human papillomavirus (HPV) infection and HPV vaccination in an Australian cohort.","volume":"153","author":"de Souza","year":"2023","journal-title":"Int J Cancer"},{"issue":"1","key":"ooi230035r22","first-page":"59","article-title":"High HPV16 E6 viral load in the oral cavity is associated with an increased number of bacteria: a preliminary study.","volume":"8","author":"Shigeishi","year":"2018","journal-title":"Biomed Rep"},{"issue":"9-10","key":"ooi230035r23","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.micinf.2017.06.001","article-title":"Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer.","volume":"19","author":"Faraji","year":"2017","journal-title":"Microbes Infect"},{"issue":"7","key":"ooi230035r24","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.adaj.2018.04.023","article-title":"Periodontitis in US adults: National Health and Nutrition Examination Survey 2009-2014.","volume":"149","author":"Eke","year":"2018","journal-title":"J Am Dent Assoc"},{"key":"ooi230035r25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.oraloncology.2015.11.013","article-title":"Oral microbiome, periodontitis and risk of head and neck cancer.","volume":"53","author":"Galv\u00e3o-Moreira","year":"2016","journal-title":"Oral Oncol"},{"issue":"9895","key":"ooi230035r26","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0140-6736(13)60809-0","article-title":"Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study.","volume":"382","author":"Kreimer","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"ooi230035r27","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jiph.2016.10.006","article-title":"Is incidence of multiple HPV genotypes rising in genital infections?","volume":"10","author":"Sohrabi","year":"2017","journal-title":"J Infect Public Health"},{"issue":"S1","key":"ooi230035r28","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.2105\/AJPH.2016.303622","article-title":"Oral health disparities: a perspective from the National Institute of Dental and Craniofacial Research","volume":"107","author":"Fischer","year":"2017;","journal-title":"Am J Public Health"},{"key":"ooi230035r2","volume-title":"IARC Monograph on the Evaluation of Carcinogenic Risks to Humans: Human Papillomaviruses","author":"World Health Organization","year":"2000"}],"container-title":["JAMA Otolaryngology\u2013Head &amp; Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/articlepdf\/2808148\/jamaotolaryngology_giuliano_2023_oi_230035_1707948225.31657.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T16:02:31Z","timestamp":1708012951000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/fullarticle\/2808148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoto.2023.1573","relation":{},"ISSN":["2168-6181"],"issn-type":[{"value":"2168-6181","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}